Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology · Pituitary Infarction

The Strategy for Treatment: Scores and Choices

At a Glance

The most critical first treatment for pituitary apoplexy is emergency hydrocortisone to prevent a life-threatening adrenal crisis. Doctors use the Pituitary Apoplexy Score (PAS) to assess your vision and alertness, helping decide if you need surgical decompression or can be safely monitored.

Managing a pituitary infarction or apoplexy is a balancing act. It requires a rapid, highly coordinated response to address three separate but overlapping issues: pressure on your brain, threats to your vision, and the sudden loss of life-sustaining hormones [1].

The First Line of Defense: Emergency Hydrocortisone

The most critical part of your initial treatment isn’t surgery or scans—it’s medication. When the pituitary gland is damaged, it often stops producing ACTH, the signal that tells your body to make cortisol (your primary stress hormone) [2].

Without cortisol, your body cannot maintain blood pressure or essential functions, which can lead to a life-threatening “adrenal crisis” [3]. For this reason, the standard of care is to give stress-dose hydrocortisone immediately, often before the diagnosis is even fully confirmed by an MRI [3][4].

Scoring Your Severity: The PAS

To decide if you need surgery or if you can be safely monitored, doctors use a tool called the Pituitary Apoplexy Score (PAS). This score helps objectively measure how much the swelling is affecting your brain and eyes [5].

The PAS evaluates four specific areas, giving points for severity:

  1. Level of Consciousness: Ranging from fully alert (0) to unresponsive (higher points).
  2. Visual Acuity: How sharp your vision is in each eye.
  3. Visual Fields: Whether you have lost peripheral (side) vision.
  4. Cranial Nerve Palsies: Whether you have double vision or a drooping eyelid. [5][6].

What the score means for you:

  • Low Score (below 4): If your vision is stable and you are alert (e.g., you might have only isolated double vision, which carries fewer points), you may be a candidate for conservative management (medical monitoring without surgery). Studies show that many stable patients recover just as well with medication alone [7][2].
  • High Score (4 or 5 and above): A higher score (e.g., profound peripheral vision loss or altered consciousness) suggests significant pressure on vital structures. In these cases, surgical decompression—a procedure to remove the pressure—is usually recommended [6][7].

Surgery vs. Conservative Management: Pros and Cons

You may be asked to participate in the decision between surgery and conservative management. Here is a breakdown of what to consider:

  • Conservative Management:
    • Pros: Avoids surgical risks like bleeding, infection, or further pituitary damage. Many patients see their double vision resolve on its own over time [8].
    • Cons: May take longer for symptoms to improve. Does not physically remove the tumor, meaning a future surgery might still be needed.
  • Surgical Decompression:
    • Pros: Rapid relief of pressure on the optic nerves, giving the best chance of reversing severe vision loss. It also removes the underlying tumor [9].
    • Cons: Carries standard surgical risks. While it relieves pressure, it rarely reverses the loss of hormone function; lifelong hormone replacement is still highly likely [10].

Timing and the Surgical Choice

If surgery is needed for stable but severe deficits (like significant peripheral vision loss), the goal is typically to perform it within the first 7 days of symptoms appearing [7][11].

Crucial Exception: If your vision loss is progressive—meaning your vision is noticeably worsening while you are in the hospital—this is an indication for immediate, urgent emergency surgery to prevent permanent blindness [7].

Your “Circle of Care”: The Multidisciplinary Team

Because this condition affects so many systems, you will be cared for by a multidisciplinary team (MDT). No single doctor should manage this condition alone [12]. Your team should include:

  • Endocrinologist: A hormone specialist who manages your steroids and long-term hormone health [13].
  • Neurosurgeon: A brain surgeon who specializes in the “transsphenoidal” (through the nose) approach to the pituitary [12].
  • Ophthalmologist: An eye specialist who uses precise machines to track even tiny changes in your visual fields [14][13].

This team will work together not just to get you through the emergency, but to plan your long-term monitoring and recovery.

Common questions in this guide

What is the Pituitary Apoplexy Score (PAS)?
The PAS is a tool doctors use to objectively measure how much swelling is affecting your brain and eyes. It evaluates your level of consciousness and vision changes to help determine if you need surgery or can be safely monitored with medication alone.
Why is emergency hydrocortisone the first treatment for pituitary infarction?
When the pituitary gland is damaged, it often stops signaling your body to make cortisol, an essential stress hormone. Emergency hydrocortisone replaces this missing hormone to prevent a life-threatening adrenal crisis and stabilize your blood pressure.
When is surgery required for pituitary apoplexy?
Surgery is typically recommended if you have a high PAS score, which indicates severe vision loss or an altered level of consciousness. Immediate emergency surgery is absolutely necessary if your vision loss is actively worsening while in the hospital.
Can pituitary apoplexy be treated without surgery?
Yes, if you have stable vision, are fully alert, and have a low PAS score, you may be a candidate for conservative management. This approach involves close medical monitoring and medication instead of undergoing brain surgery.
Which doctors will be involved in my treatment?
Because this condition affects multiple systems, you need a multidisciplinary team. This typically includes an endocrinologist to manage your hormones, a neurosurgeon if surgical decompression is needed, and an ophthalmologist to carefully track your vision.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my exact Pituitary Apoplexy Score (PAS), and how does that score influence your recommendation for surgery?
  2. 2.Is my vision loss considered 'progressive' or 'stable' according to the latest ophthalmology assessment?
  3. 3.Does my double vision warrant emergency surgery on its own, or is it managed conservatively?
  4. 4.Have I already received a 'stress dose' of hydrocortisone, and will I need long-term hormone replacement?
  5. 5.Who are the specific members of my multidisciplinary team, and how often will they coordinate my care during my hospital stay?
  6. 6.If we choose conservative management for now, what 'red flag' symptoms should I watch for that would trigger immediate surgery?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Pituitary apoplexy: pathophysiology, diagnosis and management.

    Glezer A, Bronstein MD

    Archives of endocrinology and metabolism 2015; (59(3)):259-64.

    PMID: 26154095
  2. 2

    Management of endocrine disease: update on the management of pituitary apoplexy.

    Biagetti B, Marques P, Ntali G, et al.

    European journal of endocrinology 2026; (194(2)):R49-R66 doi:10.1093/ejendo/lvag034.

    PMID: 41699778
  3. 3

    Pituitary Apoplexy Following Systemic Anticoagulation.

    Santos AR, Bello CT, Sousa A, et al.

    European journal of case reports in internal medicine 2019; (6(12)):001254 doi:10.12890/2019_001254.

    PMID: 31893198
  4. 4

    SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients.

    Baldeweg SE, Vanderpump M, Drake W, et al.

    Endocrine connections 2016; (5(5)):G12-G15 doi:10.1530/EC-16-0057.

    PMID: 27935817
  5. 5

    A key role for conservative treatment in the management of pituitary apoplexy.

    Marx C, Rabilloud M, Borson Chazot F, et al.

    Endocrine 2021; (71(1)):168-177 doi:10.1007/s12020-020-02499-8.

    PMID: 32959228
  6. 6

    Pituitary apoplexy score, toward standardized decision-making: a descriptive study.

    Salle H, Cane M, Rocher M, et al.

    Pituitary 2024; (27(1)):77-87 doi:10.1007/s11102-023-01372-x.

    PMID: 38150169
  7. 7

    The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis.

    Brown NJ, Patel S, Gendreau J, Abraham ME

    Journal of neuro-oncology 2024; (170(3)):469-482 doi:10.1007/s11060-024-04717-z.

    PMID: 39503840
  8. 8

    Pituitary apoplexy - bespoke patient management allows good clinical outcome.

    Giritharan S, Gnanalingham K, Kearney T

    Clinical endocrinology 2016; (85(3)):415-22 doi:10.1111/cen.13075.

    PMID: 27038242
  9. 9

    Surgical versus non-surgical treatment for pituitary apoplexy: A systematic review and meta-analysis.

    Tu M, Lu Q, Zhu P, Zheng W

    Journal of the neurological sciences 2016; (370()):258-262 doi:10.1016/j.jns.2016.09.047.

    PMID: 27772771
  10. 10

    Pituitary Apoplexy Case Series: Outcomes After Endoscopic Endonasal Transsphenoidal Surgery at a Single Tertiary Center.

    Pangal DJ, Chesney K, Memel Z, et al.

    World neurosurgery 2020; (137()):e366-e372 doi:10.1016/j.wneu.2020.01.204.

    PMID: 32032792
  11. 11

    Pituitary Apoplexy and the Current Understanding of Its Management: A Meta-Analysis of 908 Patients.

    Marin-Castañeda LA, Gorbachev J, Lopez-Zepeda PT, et al.

    World neurosurgery 2024; (190()):371-385.e1 doi:10.1016/j.wneu.2024.07.103.

    PMID: 39033812
  12. 12

    Multidisciplinary Management of Pituitary Apoplexy.

    Albani A, Ferraù F, Angileri FF, et al.

    International journal of endocrinology 2016; (2016()):7951536 doi:10.1155/2016/7951536.

    PMID: 28074095
  13. 13

    Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.

    Kuhn E, Weinreich AA, Biermasz NR, et al.

    European journal of endocrinology 2021; (185(1)):99-108.

    PMID: 33914699
  14. 14

    Pituitary apoplexy within a prolactin-secreting macroadenoma in a child: A rare clinical entity with radiological correlation.

    Mouhcine Y, Lahjouji O, Ouazzani H, et al.

    Radiology case reports 2025; (20(11)):5583-5589 doi:10.1016/j.radcr.2025.07.066.

    PMID: 40895003

This page provides educational information about pituitary apoplexy treatment strategies and the PAS score. It does not replace professional medical advice from your endocrinologist or neurosurgical team.

Get notified when new evidence is published on pituitary gland infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.